ArticleFrontiers in pharmacology2021

Bulleyaconitine A Inhibits Morphine-Induced Withdrawal Symptoms, Conditioned Place Preference, and Locomotor Sensitization Via Microglial Dynorphin A Expression.

Meng-Jing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.